The Fight Against Toenail Fungus Goes High-Tech in Australia with Launch of Breakthrough PinPointe FootLaser Treatment

CHICO, Calif.--(BUSINESS WIRE)--PinPointe USA, Inc., a privately held emerging medical device company developing advanced laser-based technology and products for the treatment of onychomycosis (toenail fungus) today announced that it has certified its first PinPointe FootLaser Provider in Australia to administer its revolutionary new treatment for toenail fungus. The Certified Provider, Paul W. Bours, Podiatric Surgeon, is currently offering the PinPointe FootLaser treatment at the Institute of Surgical Podiatry in Sydney, Australia. The PinPointe FootLaser received approval last year from the Therapeutic Goods Administration (TGA), certifying it has met the TGA’s consumer and health safety standards and can be offered by certified health care providers throughout Australia.